racemetirosine has been researched along with Ischemia in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yapca, OE | 1 |
| Yildiz, GA | 1 |
| Mammadov, R | 1 |
| Kurt, N | 1 |
| Gundogdu, B | 1 |
| Arslan, YK | 1 |
| Suleyman, H | 1 |
| Cetin, N | 1 |
1 other study available for racemetirosine and Ischemia
| Article | Year |
|---|---|
The effects of metyrosine on ischemia-reperfusion-induced oxidative ovarian injury in rats: Biochemical and histopathological assessment.
Topics: alpha-Methyltyrosine; Animals; Cyclooxygenase 2; Female; Glutathione; Ischemia; Ovary; Oxidative Str | 2023 |